• No se han encontrado resultados

Promotor methylation: Does it affect response to therapy in chronic hepatitis C (G4) or fibrosis?

N/A
N/A
Protected

Academic year: 2020

Share "Promotor methylation: Does it affect response to therapy in chronic hepatitis C (G4) or fibrosis?"

Copied!
7
0
0

Texto completo

Loading

Figure

Table 1. Primers sequences and conditions of the methylation specific PCR (MSP).
Table 3. Clinico-pathological features of the responder and non- responder patients
Table 5. The methylation status of the studied group in relation to IFN response.

Referencias

Documento similar

In summary, the data presented here show for the first time that pharmacological inhibition of RPTPβ/ζ with MY10 significantly reduces chronic voluntary ethanol consumption only

Introduction: The aim of this study is to evaluate results in a series of patients with chronic posterior-lateral instability of the elbow treated with reconstruction of the

Prospective observational study evaluating the association of 124 polymorphisms with the response to adalimumab or infliximab (PASI75) in patients with moderate-to-severe

Figure 3 shows a similar experiment, but the panels have been changed to show the belief indicators for the word associated with the 'north' direction (left panel) and the population

* Study showing the efficacy of tocilizumab in systemic juvenile idiopathic arthritis, a chronic inflammatory disease that in some cases may be associated with the development

The purpose of this study is to report a new surgical technique and the comparative clinical outcomes in patients with primary tenorrhaphy rupture or chronic flexor digitorum

The assessment of perceived health status in patients with chronic diseases is essential for measuring the impact and burden of disease, as in the case of patients with

Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib. Doshi,